Skip to main content

tafenoquine

Generic: tafenoquine·Brand: ARAKODA, KRINTAFEL

tafenoquine: 6 clinical trials tracked.

tafenoquine evidence translation

What we can confirm

6 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about tafenoquine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Clinical Trials (6)

Expanded Access Protocol: Use of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients With Persistent Babesia Microti Despite Prior Treatment

Available
Expanded Access60 Degrees Pharmaceuticals LLC

B-FREE Chronic Babesiosis Study: A Phase 2 Open Label Study of Tafenoquine for Treatment of Chronic Babesiosis Patients With Severe Fatigue

NCT06656351·Phase 2·SXTP
Recruiting

Primary endpoint: Change in General Fatigue

Interventionalopen40 targetStarted 2025-11Completion 2027-091 site · United States60 Degrees Pharmaceuticals LLC

A Double-blind Placebo-controlled Study to Assess the Safety and Efficacy of Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care in Patients Hospitalized for Babesiosis

NCT06207370·Phase 2·SXTP
Recruiting

Primary endpoint: Time to sustained clinical resolution

InterventionalRandomizedquadruple33 targetStarted 2024-06Completion 2027-071 site · United States60 Degrees Pharmaceuticals LLC

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria - TAfenoquine DOsing REvised

NCT06148792·Phase 3
Recruiting

Primary endpoint: The incidence risk of vivax parasitaemia

InterventionalRandomizedopen1,090 targetStarted 2024-05Completion 2027-034 sites · Brazil, Ethiopia, Indonesia, Papua New GuineaMenzies School of Health Research

Health Care Provider Use of Plasmodium Vivax Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

Completed

Primary endpoint: To assess health care provider (HCP) compliance to a revised case management algorithm for vivax malaria that involves providing radical cure (RC) after G6PD testing and a follow-up visit on day 3 days [+ 2 days])

Observational187 enrolledStarted 2023-08Completion 2024-121 site · PeruMedicines for Malaria Venture

Single Site, Randomized, Double Blind, Placebo-Controlled Study to Assess the Long-Term Safety of Tafenoquine

NCT03320174·Phase 2·SXTP
Completed

Primary endpoint: Serious Ophthalmic Safety Event

InterventionalRandomizedquadruple600 enrolledStarted 2017-10Completion 2021-073 sites · Australia, United States60 Degrees Pharmaceuticals LLC